Insulin Suppresses Plasma Concentration of Vascular Endothelial Growth Factor and Matrix Metalloproteinase-9

Diabetes Care

Volumn 26, Issue 12, 2003, Pages 3310-3314

  Dandona, Paresh ^a   Aljada, Ahmad ^b   Mohanty, Priya ^b   Ghanim, Husam ^b   Bandyopadhyay, Arindam ^b   Chaudhuri, Ajay ^b  

^a Diabetes Endocrinology Center of Western New York   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; GLUCOSE; INSULIN; POTASSIUM CHLORIDE; SODIUM CHLORIDE; VASCULOTROPIN;

ADULT; ARTICLE; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; HEALTH STATUS; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INSULIN INFUSION; MALE; NORMAL HUMAN; OBESITY; PLASMA; STATISTICAL SIGNIFICANCE;

ADULT; GLUCOSE; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; OBESITY; SODIUM CHLORIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0344844386     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.12.3310     Document Type: Article

References (28)

1. Brown GC, Magargal LE, Federman JL: Ischaemia and neovascularization. Trans Ophthalmol Soc U K 100:377-380, 1980
2. Verma D: Pathogenesis of diabetic retinopathy: the missing link? Med Hypotheses 41:205-210, 1993
3. Forsythe JA, Jiang BH, lyer NV, Agani F, Leung SW, Koos RD, Semenza GL: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-4613, 1996
4. Ozaki H, Yu AY, Della N, Ozaki K, Luna JD, Yamada H, Hackett SF, Okamoto N, Zack DJ, Semenza GL, Campochiaro PA: Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci 40:182-189, 1999
5. Thurston G, Suri C, Smith. K, McClain J, Sato TN, Yancopoulos GD, McDonald DM: Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286:2511-2514, 1999
6. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J: Vascular-specific growth factors and blood vessel formation. Nature 407:242-248, 2000
7. Gamble JR, Drew J, Trezise L, Underwood A, Parsons M, Kasminkas L, Rudge J, Yancopoulos G, Vadas MA: Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 87:603-607, 2000
8. Celletti FL, Waugh JM, Amabile PG, Brendolan A, Hilfiker PR, Dake MD: Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 7:425-429, 2001
9. Ross R: Atherosclerosis: an inflammatory disease. N Engl J Med 340:115-126, 1999
10. Jeziorska M, Woolley DE: Neovascularization in early atherosclerotic lesions of human carotid arteries: its potential contribution to plaque development. Hum Pathol 30:919-925, 1999
11. Wang H, Keiser JA: Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Circ Res 83:832-840, 1998
12. Zucker S, Mirza H, Conner CE, Lorenz AF, Drews MH, Bahou WF, Jesty J: Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer 75:780-786, 1998
13. Rohde LE, Ducharme A, Arroyo LH, Aikawa M, Sukhova GH, Lopez-Anaya A, McClure KF, Mitchell PG, Libby P, Lee RT: Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 99:3063-3070, 1999
14. Newby AC, Libby P, van der Wal AC: Plaque instability: the real challenge for atherosclerosis research in the next decade? (Editorial). Cardiovasc Res 41:321-322, 1999
15. Aljada A, Saadeh R, Assian E, Ghanim H, Dandona P: Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J Endocrinol Metab 85:2572-2575, 2000
16. Aljada A, Ghanim H, Saadeh R, Dandona P: Insulin inhibits NFkappaB and MCP-1 expression in human aortic endothelial cells. J Endocrinol Metab 86:450-453, 2001
17. Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S: Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anli-inflammatory effect? J Endocrinol Metab 86:3257-3265, 2001
18. Aljada A, Mohanty P, Ghanim H, Tripathy D, Kapur N, Dandona P: Insulin inhibits the pro-inflammatory transcription factor early growth response-1 (Egr-1) expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J Endocrinol Metab. In press
19. Marumo T, Schini-Kerth VB, Busse R: Vascular endothelial growth factor activates nuclear factor-KB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 48:1131-1137, 1999
20. Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY: Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276:7614-7620, 2001
21. Natarajan R, Bai W, Lanting L, Gonzales N, Nadler J: Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am J Physiol 273:H2224-H2231, 1997
22. Miyamoto K, Khosrof S, Bursell SE, Moromizato Y, Aiello LP, Ogura Y, Adamis AP: Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (1CAM-1). Am J Pathol 156:1733-1739, 2000
23. Barouch FC, Miyamoto K, Allport JR, Fujita K, Bursell SE, Aiello LP, Luscinskas FW, Adamis AP: Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest Ophthalmol Vis Sci 41:1153-1158, 2000
24. Hellwig-Burgel T, Rutkowski K, Metzen E, Fandrey J, Jelkmann W: Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 94:1561-1567, 1999
25. Lu M, Amano S, Miyamoto K, Garland R, Keough K, Qin W, Adamis AP: Insulin-induced vascular endothelial growth factor expression in retina. Invest Ophthalmol Vis Sci 40:3281-3286, 1999
26. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
27. Shichiri M, Kishikawa H, Ohkubo Y, Wake N: Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 23 (Suppl. 2):B21-B29, 2000
28. Brinchmann-Hansen O, Dahl-Jorgensen K, Sandvik L, Hanssen KF: Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study. BMJ 304:19-22, 1992